fbpx An update on Mmr | Page 178 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

A help desk for small and medium enterprises in Horizon 2020

As part of the European programme Horizon 2020, which has allocated € 70 billion for research and innovation, Sapienza Innovazione, a promoter of high tech companies born in 2006, and Management Innovation, a society founded in 2008 that works in innovation consulting, have recently set up a SME (Small and Medium Sizes Enterprises) help desk in support of SMEs that want to innovate. This help desk is called Sportello